Pharm
Inhaled Insulin
search
Inhaled Insulin
, Insulin Inhalation Powder, Afrezza, Exubera
See Also
Insulin
Bolus Insulin
Analog Basal Insulin
Insulin Dosing
Glucose Metabolism
Type II Diabetes Medications
Type 1 Diabetes Mellitus
Indications
Bolus Insulin
in
Diabetes Mellitus
when intollerant to
SQ Injection
Contraindications
COPD
Asthma
Chronic lung disease
Lung Cancer
Tobacco
use
Mechanism
Dry powder form of rapid acting
Insulin
Delivery by oral inhalation
Large doses needed due to inefficient absorption
Most
Insulin
remains in lung and is inactive
Medications
Afrezza
Background
Released in 2014, as a
Bolus Insulin
(
Short-Acting Insulin
) substitute
Does not replace
Basal insulin
(
Long-Acting Insulin
)
Not approved for use in children
Supplied
Delivered in 4, 8 or 12 units/cartridge
Convert
Insulin
unit for unit, and round dose up to nearest 4 unit cartridge
Dosing:
Insulin
Naive
Start: 4 units inhaled immediately before meals
Dosing: Switching from
Bolus Insulin
(
Short-Acting Insulin
)
Convert unit for unit of prior
Bolus Insulin
to Inhaled Insulin, rounding to nearest 4 units (4 to 24 units)
Dosing: Switching from Pre-mixed
Insulin
(e.g. 70/30 or 50/50)
Inhaled Dose: Divide 50% of total daily premixed
Insulin
equally over 3 meals
Give Inhaled Insulin dose, rounding to nearest 4 units (4 to 24 units), immediately before meals
Cost
Twice the cost of
Bolus Insulin
Activity
Onset of activity is similar to SC injected
Bolus Insulin
Duration is shorter than SC injected
Bolus Insulin
Medications
Exubera (off market as of 2007)
Historical information only
Off U.S. Market as of October 2007 (based on business decisions, not on recall)
Dosing
Powder 1 mg (in
Blister
pack) =
Insulin
3 units
Powder 3 mg (in
Blister
pack) =
Insulin
8 units
Preparations
Starter:
Inhaler
/parts, 180 packs 1 mg, 90 packs 3 mg
Refill 12: 90 packs 1 mg, 90 packs 3 mg (990 units)
Refill 15: 180 packs 1 mg, 90 packs 3 mg (1260 units)
Cost: Expensive (twice the cost of SQ
Insulin
)
Starter: $190
Refills: $140-180
Efficacy
Similar to SC
Bolus Insulin
Safety
Unknown safety in pregnancy
Unknown safety in
Lactation
Adverse Effects
Exubera
Hypoglycemia
(esp. when used with
Oral Hypoglycemic
s)
Bronchospasm
Cough
(<5%)
Chest Pain
(<5%)
Dyspnea
(<5%)
Dry Mouth
(<5%)
Monitoring
Pulmonary Function Test
s
Schedule: Baseline, 6 months and annually
Stop Inhaled Insulin if
FEV1
with >20% decline from baseline
Resources
Afrezza (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29f4637b-e204-425b-b89c-7238008d8c10
References
(2015) Presc Lett 22(3): 13-4
Borja (2007) Am Fam Physician 75: 1546-7 [PubMed]
Cefalu (2001) Ann Intern Med 134:203-7 [PubMed]
Quattrin (2004) Diabetes Care 27:2622-7 [PubMed]
Type your search phrase here